Home > Research > Publications & Outputs > Missing not at random in end of life care studies

Text available via DOI:

View graph of relations

Missing not at random in end of life care studies: multiple imputation and sensitivity analysis on data from the ACTION study

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
  • ACTION Consortium
Close
Article number13
<mark>Journal publication date</mark>9/01/2021
<mark>Journal</mark>BMC Medical Research Methodology
Issue number1
Volume21
Number of pages12
Publication StatusPublished
<mark>Original language</mark>English

Abstract

BACKGROUND: Missing data are common in end-of-life care studies, but there is still relatively little exploration of which is the best method to deal with them, and, in particular, if the missing at random (MAR) assumption is valid or missing not at random (MNAR) mechanisms should be assumed. In this paper we investigated this issue through a sensitivity analysis within the ACTION study, a multicenter cluster randomized controlled trial testing advance care planning in patients with advanced lung or colorectal cancer.

METHODS: Multiple imputation procedures under MAR and MNAR assumptions were implemented. Possible violation of the MAR assumption was addressed with reference to variables measuring quality of life and symptoms. The MNAR model assumed that patients with worse health were more likely to have missing questionnaires, making a distinction between single missing items, which were assumed to satisfy the MAR assumption, and missing values due to completely missing questionnaire for which a MNAR mechanism was hypothesized. We explored the sensitivity to possible departures from MAR on gender differences between key indicators and on simple correlations.

RESULTS: Up to 39% of follow-up data were missing. Results under MAR reflected that missingness was related to poorer health status. Correlations between variables, although very small, changed according to the imputation method, as well as the differences in scores by gender, indicating a certain sensitivity of the results to the violation of the MAR assumption.

CONCLUSIONS: The findings confirmed the importance of undertaking this kind of analysis in end-of-life care studies.